🔍

Kothari Fermentation & Biochem Ltd (507474)

📊 BSE: 507474 🏢 Other Food Products 📢 Latest filing: 07 Oct 2026

Latest quarterly results (Q1 FY27)

In its latest reported quarter, Q1 FY27, Kothari Fermentation's revenue was ₹30.4 Cr (+28.1% year on year, -6.3% on the previous quarter), and net profit ₹0.1 Cr (against a loss a year earlier); the operating margin was 8.7%.

Q1 FY27 (₹ Cr)	Value	YoY vs Q1 FY26	QoQ
Revenue	₹30.4	+28.1%	-6.3%
Operating profit	₹2.7	+59.7%	-8.9%
Net profit	₹0.1	from loss	-94.9%
EPS (₹)	0.04	from loss	-95.3%
Operating margin	8.7%	—	—

Full quarterly financials → Results calendar →

📢 Recent Corporate Announcements

Kothari Fermentation Signs Commercial Pact With Rs 1,078 Cr Paid-Up Oriental Yeast India

🟢 POSITIVE ⭐ 6/10

OTHER 📅 07 Oct 2026, 11:29 AM

Kothari Fermentation and Biochem Ltd (KFBL) has entered into commercial agreements on October 6, 2026, with Oriental Yeast India Private Limited (OYI), a subsidiary of Japan's Oriental Yeast Co. Ltd. Under the agreement, KFBL will provide manufacturing services, while OYI will provide technical support and distribution services for yeast and related products. There is no upfront consideration paid or received, and no change in management control. For KFBL, which generated Rs 119 Cr TTM revenue and has a market cap of Rs 62 Cr, partnering with an entity having a paid-up capital of Rs 1,078.05 Cr could improve manufacturing efficiency and product quality.

Agreement executed on October 6, 2026, covering yeast and related products within the domestic market
Partner Oriental Yeast India Private Limited has a paid-up capital of Rs 1,078.05 Crores and is backed by Oriental Yeast Co. Ltd. (Japan)
KFBL will handle manufacturing services, while OYI will deliver technical support and distribution services
No upfront financial consideration involved, and zero impact on KFBL's management or control

💡 Track upcoming quarterly results to see if technical collaboration improves operating margins (OPM was 5.8% in FY26) or increases utilization via OYI's distribution network.

Kothari Fermentation Shareholders Approve All 36th AGM Resolutions, Remuneration Revisions Pass

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 30 Sep 2026, 07:47 PM

Kothari Fermentation & Biochem Ltd announced the voting results of its 36th Annual General Meeting held on September 30, 2026. All four resolutions were passed with the requisite majority, comprising adoption of FY26 audited accounts, re-appointment of Director Pramod Kumar Kothari, and remuneration revisions for Pramod Kumar Kothari and Kavita Devi Kothari. Overall, 10,682,580 votes were cast representing 71.22% of total shares, driven overwhelmingly by promoter support (10,330,315 votes). Notably, 43.67% of voting non-institutional public shareholders dissented against the remuneration hike resolutions, though both passed comfortably with 98.56% aggregate approval.

Total of 10,682,580 valid votes cast out of 15,000,000 total shares, representing a 71.2172% voter turnout
Adoption of FY26 financials and re-appointment of Pramod Kumar Kothari approved with 99.98% votes in favour
Special resolutions on remuneration revisions for Pramod Kumar Kothari and Kavita Devi Kothari passed with 98.56% overall assent
Non-institutional public voters showed 43.67% dissent (153,833 votes against) regarding both managerial remuneration resolutions

💡 Track the upcoming Q2 FY27 operational results and notes to accounts to assess the exact financial impact of the approved managerial remuneration increases on corporate overheads.

Kothari Fermentation: Resignation of Internal Auditor Arun K. Garg & Associates

🟡 NEUTRAL ⭐ 3/10

MANAGEMENT 📅 25 Sep 2026, 06:08 PM

Kothari Fermentation & Biochem Ltd announced the resignation of its Internal Auditor, M/s. Arun K. Garg & Associates, for FY 2026-27, effective September 25, 2026. The firm cited preoccupation with other professional assignments and lack of resources as reasons for resignation via letter dated September 22, 2026. The company stated it is currently in the process of identifying and appointing a new Internal Auditor. This is an administrative compliance disclosure and does not impact operating performance.

Internal Auditor M/s. Arun K. Garg & Associates resigned effective September 25, 2026
Resignation tendered for FY 2026-27 due to preoccupation and lack of resources
Resignation letter dated September 22, 2026, received by the company on September 25, 2026
Company is in the process of appointing a new Internal Auditor

💡 Watch for the subsequent board intimation announcing the appointment of the successor Internal Auditor to ensure standard internal audit continuity.

₹30.4 Cr Q1 Revenue: Kothari Fermentation Returns to Profitability YoY

🟢 POSITIVE ⭐ 6/10

EARNINGS 📅 13 Aug 2026, 06:03 PM

Kothari Fermentation & Biochem reported a 28% YoY revenue growth to ₹30.41 Cr for Q1 FY27. The company achieved a marginal turnaround with a Net Profit of ₹6.45 Lakhs, compared to a loss of ₹1.12 Cr in the same quarter last year. However, performance weakened sequentially compared to Q4 FY26, where revenue was ₹32.47 Cr and PAT was ₹1.27 Cr. The company remains heavily reliant on its 'Yeast' segment, which now includes cattle feed synergies.

Revenue from operations increased 28% YoY to ₹30.41 Cr from ₹23.75 Cr.
Net Profit turned positive at ₹6.45 Lakhs vs a loss of ₹1.12 Cr in Q1 FY26.
Cost of materials consumed rose significantly to ₹15.40 Cr, up 44.7% from ₹10.64 Cr YoY.
Finance costs increased to ₹91.32 Lakhs from ₹79.57 Lakhs in the previous year's quarter.
The 36th Annual General Meeting (AGM) is scheduled for September 30, 2026.

💡 Investors should monitor the company's ability to maintain positive bottom-line results given the extremely thin margins (PAT margin < 0.3%). Watch for stabilization in raw material and power costs, which represent the bulk of expenses.

Rs 30.41 Cr Revenue: Kothari Fermentation Turns Profitable YoY in Q1 FY27

🟡 NEUTRAL ⭐ 6/10

EARNINGS 📅 13 Aug 2026, 05:45 PM

Kothari Fermentation & Biochem reported a 28% YoY increase in revenue to Rs 30.41 Cr for the quarter ended June 30, 2026. The company achieved a marginal net profit of Rs 6.45 Lakhs, a recovery from the Rs 1.12 Cr loss reported in the same quarter last year. However, profitability saw a significant sequential decline from the Rs 1.27 Cr profit recorded in March 2026. Operating margins remain extremely tight, with total expenses of Rs 30.41 Cr nearly equaling total income.

Revenue from operations grew 28% YoY to Rs 30.41 Cr from Rs 23.75 Cr.
Net profit turned positive at Rs 6.45 Lakhs vs a loss of Rs 1.12 Cr in Q1 FY26.
Power and fuel costs remained a major expense at Rs 6.23 Cr, representing 20.5% of revenue.
Finance costs increased to Rs 0.91 Cr compared to Rs 0.80 Cr in the year-ago period.
The 36th Annual General Meeting (AGM) is scheduled for September 30, 2026.

💡 Investors should monitor the company's ability to improve operating margins, which are currently near break-even. The integration of the cattle feed segment with the core yeast business is the key structural development to track for future margin expansion.

Kothari Fermentation Board Meeting on Aug 13, 2026, for Q1 Results and 36th AGM

🟡 NEUTRAL ⭐ 3/10

BOARD_MEETING 📅 07 Aug 2026, 03:53 PM

Kothari Fermentation & Biochem Ltd has scheduled a board meeting on August 13, 2026, to approve unaudited financial results for the quarter ended June 30, 2026. The company is currently loss-making on a TTM basis with a net loss of ₹3 Cr, despite a profitable March 2026 quarter (PAT ₹1.27 Cr). The board will also finalize the notice for the 36th Annual General Meeting. Investors will be monitoring if the company can sustain the operational turnaround seen in the previous quarter given its high debt of ₹48 Cr relative to its ₹66 Cr market cap.

Board meeting scheduled for August 13, 2026, to review Q1 FY27 performance.
Company to finalize the notice and agenda for the 36th Annual General Meeting.
Trading window for designated persons has been closed since June 25, 2026.
Previous year's corresponding quarter (June 2025) saw a net loss of ₹1.12 Cr.
Current TTM revenue stands at ₹112 Cr with a debt-to-equity ratio of 0.89.

💡 Monitor the financial results on August 13 to verify if the company maintains the 9% operating margin achieved in the March 2026 quarter or reverts to the lower margins seen earlier in FY26.

View All 507474 Announcements on Live Market Tracking →